Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials-Reference-Cited by-同舟云学术

Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials

Published:2016-06 Issue: Volume:8 Page:309-316
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Proietti Marco,Lane Deirdre A.,Lip Gregory Y.H.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference32 articles.

1. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial;Albers;JAMA,2005

2. Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial;Apostolakis;Eur. Heart J.,2013

3. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley atrial fibrillation project;Banerjee;J. Am. Coll. Cardiol.,2013

4. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley atrial fibrillation project;Banerjee;Chest,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Clinical Outcomes of Warfarin Use Among Patients with Chronic Kidney Disease in Thailand;Journal of the Medical Association of Thailand;2023-12-25

2. Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D;Thrombosis Research;2023-09

3. Analysis of drug prescriptions of patients with atrial fibrillation in combination with chronic kidney disease for compliance with STOPP/START criteria;Medical alphabet;2022-11-25

4. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry;BMC Medicine;2022-09-02

5. Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D;Clinical Kidney Journal;2022-01-28